Elective minimally invasive (laparoscopic or robotic) resection of colorectal cancer.
American Society of Anesthesiologists classification (ASA) 1-4.
Able to understand the research process and the use of various assessment scales, and able to communicate effectively with the researchers.
The patient voluntarily participates in this study and signs the informed consent form.
You may not be if
Previous history of abdominal gastrointestinal surgery.
Planned for palliative or emergency surgery.
Planned for open abdominal surgery or creation of a new stoma.
Transfer to ICU.
Diagnosed with severe heart, liver, kidney or mental system diseases.
Patients with implanted cardiac pacemakers.
Patients currently using or having used in the past month glucagon-like peptide-1 (GLP-1) receptor agonists, dual glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and sodium-glucose cotransporter-2 (SGLT-2) inhibitors.
Planned to use epidural anesthesia or epidural analgesia.
Presence of local skin lesions, infection at the stimulation site, or obvious skin allergy or severe skin sensitivity to electrodes/adhesive materials.
Participated in other clinical studies within the past 3 months or received acupuncture treatment within the past month.
Other conditions that the investigator considers make the patient unsuitable for participation in this study.
